Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 100,000 shares at $20.14 ($2.0M) on 2023-07-11, disclosed to the SEC on 2023-07-13.
Scheduled sale ($2.0M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.14 | 24,384 | $491K | 24.3% |
| 2 | $20.14 | 24,384 | $491K | 24.3% |
| 3 | $20.17 | 11,459 | $231K | 11.4% |
| 4 | $20.17 | 11,459 | $231K | 11.4% |
| 5 | $20.35 | 14,157 | $288K | 14.3% |
| 6 | $20.35 | 14,157 |
| $288K |
| 14.3% |
| Total | $20.21 avg | 100,000 | $2.0M | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |